Europe Cardiovascular Ultrasound Market Forecast 2022-2030

The Europe cardiovascular ultrasound market is predicted to develop with a CAGR of 5.81% across the forecasted period of 2022 to 2030. The regional market's growth is propelled by the rising geriatric population, stressful work environments, government programs as well as initiatives propagating cardiac ultrasound systems, and changing lifestyles.

MARKET INSIGHTS

The Europe cardiovascular ultrasound market growth analysis comprises the assessment of Nordic Countries, Germany, the United Kingdom, Spain, France, Italy, Poland, and Rest of Europe. A cardiovascular incident occurs every four minutes in France. Moreover, such diseases, impacting the population's younger segments, are presently the second-leading cause of death in the country. Obesity is also rising in France and impacts 17% of the population. Besides, 15% of children in the country are overweight, as well. In 2020, more than 63,100 people died from coronary heart disease in France, accounting for nearly 13.22% of all deaths.

Conversely, cardiovascular disease (CVD) is the leading reason for mortality among Type 2 Diabetes (T2D) patients in Italy, equating to 42% of deaths. Estimates also suggest that deaths linked to coronary heart disease in Italy reached 97,116 in the year 2020, accounting for 17.89% of the overall deaths. Numerous factors, primarily biological, behavioral, and psychosocial, may play a substantial role in the prevalence of cardiac disease as well as coronary heart disease in the country, thus fueling the demand for cardiovascular ultrasounds. As a result, these factors are set to augment the market growth in Europe during the forecasted period.

COMPETITIVE INSIGHTS

Some of the leading companies in the market are: Siemens Healthineers, Philips Healthcare, Esaote, etc.

Our report offerings include:

Explore key findings of the overall market

Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)

Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions

Market Segmentation caters to a thorough assessment of key segments with their market estimations

Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share

Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.

Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.

Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Product Code: 16319

1. RESEARCH SCOPE & METHODOLOGY

1.1. STUDY OBJECTIVES
1.2. SCOPE OF STUDY
1.3. METHODOLOGY
1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

2.1. MARKET SIZE & ESTIMATES
2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

3.1. KEY DRIVERS
- 3.1.1. RISING CARDIOVASCULAR DISEASES
- 3.1.2. TECHNOLOGICAL ADVANCEMENTS
3.2. KEY RESTRAINTS
- 3.2.1. LACK OF AWARENESS AMONG PATIENTS
- 3.2.2. STRINGENT REGULATIONS

4. KEY ANALYTICS

4.1. IMPACT OF COVID-19 ON CARDIOVASCULAR ULTRASOUND MARKET
4.2. KEY MARKET TRENDS
4.3. PORTER'S FIVE FORCES ANALYSIS
- 4.3.1. BUYERS POWER
- 4.3.2. SUPPLIERS POWER
- 4.3.3. SUBSTITUTION
- 4.3.4. NEW ENTRANTS
- 4.3.5. INDUSTRY RIVALRY
4.4. OPPORTUNITY MATRIX
4.5. VENDOR LANDSCAPE
4.6. VALUE CHAIN ANALYSIS
4.7. KEY BUYING CRITERIA
- 4.7.1. QUALITY
- 4.7.2. DURABILITY
- 4.7.3. PRICE
- 4.7.4. TECHNOLOGY
4.8. REGULATORY FRAMEWORK

5. MARKET BY DISPLAY

5.1. BLACK AND WHITE
5.2. COLOR

6. MARKET BY TECHNOLOGY

6.1. 2D
6.2. 3D/4D
6.3. DOPPLER

7. MARKET BY TYPE

7.1. TRANSTHORACIC ECHOCARDIOGRAPHY
7.2. FETAL ECHOCARDIOGRAPHY
7.3. TRANSESOPHAGEAL ECHOCARDIOGRAPHY
7.4. OTHER TYPES

8. MARKET BY END-USER

8.1. HOSPITALS
8.2. DIAGNOSTIC CENTERS
8.3. AMBULATORY CARE CENTERS
8.4. OTHER END-USERS

9. GEOGRAPHICAL ANALYSIS

9.1. EUROPE
- 9.1.1. MARKET SIZE & ESTIMATES
- 9.1.2. KEY GROWTH ENABLERS
- 9.1.3. KEY CHALLENGES
- 9.1.4. KEY PLAYERS
- 9.1.5. COUNTRY ANALYSIS
  - 9.1.5.1. UNITED KINGDOM
  - 9.1.5.2. GERMANY
  - 9.1.5.3. FRANCE
  - 9.1.5.4. ITALY
  - 9.1.5.5. SPAIN
  - 9.1.5.6. NORDIC COUNTRIES
  - 9.1.5.7. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

10.1. KEY STRATEGIC DEVELOPMENTS
- 10.1.1. PRODUCT LAUNCHES & DEVELOPMENTS
- 10.1.2. PARTNERSHIPS & AGREEMENTS
10.2. COMPANY PROFILES
- 10.2.1. CANON MEDICAL SYSTEMS CORPORATION
- 10.2.2. CLARIUS
- 10.2.3. DAWEI MEDICAL
- 10.2.4. ESAOTE SPA
- 10.2.5. FUJIFILM HOLDINGS CORPORATION
- 10.2.6. GE HEALTHCARE
- 10.2.7. LANMAGE
- 10.2.8. LELTEK
- 10.2.9. MINDRAY MEDICAL INTERNATIONAL LIMITED
- 10.2.10. PHILIPS HEALTHCARE
- 10.2.11. SAMSUNG MEDISON CO LTD
- 10.2.12. SIEMENS HEALTHINEERS
- 10.2.13. TELEMED ULTRASOUND MEDICAL SYSTEMS
- 10.2.14. VIATOM TECHNOLOGY CO
- 10.2.15. ZONCARE